Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AbundRX vs Alloy

AbundRX
Graded #192

Lower grade

vs+5.700000000000003
Alloy
Graded #84

Higher grade

The verdict

Alloy takes it — 72/100 to 66.3/100.

Alloy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alloy is a menopause-focused telehealth brand whose Weight Care program runs the broadest GLP-1 formulary in our catalog — brand Wegovy, brand Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlloy +3
66
69
Dose & formulationAlloy +29
64
93
Clinical oversightEven
79
79
Labs & monitoringAlloy +1
53
54
FulfillmentAbundRX +9
74
65
Contract termsEven
55
55
AbundRX · left barAlloy · right bar

The numbers

MetricAbundRXAlloy
WeighScore66.3/10072/100
GradeCC
Scorecard rank#192#84
Semaglutide$179/mo (compounded)$169/mo (compounded)
Tirzepatide$279/mo (compounded)$199/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
AbundRX

Graded #192 · C

Strengths

  • Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
  • Fast, free shipping and a simple few-minute online health assessment
  • Provider-guided care connecting patients with licensed US clinicians
  • Publishes Terms, Privacy, and Refund policies

Where it loses points

  • Claims LegitScript certification in text but displays no verifiable seal or listing
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy not named; no HIPAA notice found; state availability not published
  • Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
Alloy

Graded #84 · C

Strengths

  • Broadest GLP-1 formulary here: brand Wegovy and Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide, and liraglutide
  • All consulting doctors are certified by The Menopause Society — a rare credential
  • STARTGLP1 promo code takes $50 off the first month
  • Spans the price range: compounded semaglutide from $70/mo, brand Wegovy from $199/mo (each plus the $99/mo Weight Care fee)

Where it loses points

  • Menopause-focused — best for women in menopause or perimenopause, not men or younger patients
  • A mandatory $99/mo Alloy Weight Care fee sits on top of every medication price (so the true minimum is ~$169/mo, not $70)
  • Compounded semaglutide not available in AL, AR, CA, NV, LA, MS or DC

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard